content: <HTML>
  <HEAD>
  <TITLE></TITLE>
  </HEAD>
  <BODY STYLE="font-size: 10pt">
  
  
  <P STYLE="margin: 0; text-align: center">UNITED STATES</P>
  
  <P STYLE="margin: 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>
  
  <P STYLE="margin: 0; text-align: center">Washington, D.C. 20549</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">FORM 8-K</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">CURRENT REPORT</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">Date of Report (Date of earliest event reported): <B>December 17, 2014</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>GREENESTONE HEALTHCARE CORPORATION</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Exact name of registrant as specified in its charter)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
      <TD STYLE="width: 34%; border-bottom: black 1pt solid; text-align: center"><B>Colorado</B></TD>
      <TD STYLE="width: 1%; font-size: 12pt; text-align: center">&nbsp;</TD>
      <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><B>000-15078</B></TD>
      <TD STYLE="width: 1%; font-size: 12pt; text-align: center">&nbsp;</TD>
      <TD STYLE="width: 32%; border-bottom: black 1pt solid; text-align: center"><B>84-1227328</B></TD></TR>
  <TR STYLE="vertical-align: top">
      <TD STYLE="text-align: center">(State of Incorporation)</TD>
      <TD STYLE="margin: 0; text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">(Commission File Number)</TD>
      <TD STYLE="margin: 0; text-align: center">&nbsp;</TD>
      <TD STYLE="text-align: center">(IRS Employer Number)</TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: center"><B>&nbsp;</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>5734 Yonge Street, Suite 300</B></P>
  
  <P STYLE="margin: 0; text-align: center"><B>North York, Ontario, Canada M2M 4E7</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Address of principal executive offices)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center"><B>(416) 222-5501</B></P>
  
  <P STYLE="margin: 0; text-align: center">(Registrant&#8217;s telephone number, including
  area code)</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;Prepared By:</P>
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 76px; width: 151px"></P>
  
  <P STYLE="margin: 0; text-align: center">Attn: Sunny Barkats, Esq.,</P>
  
  <P STYLE="margin: 0; text-align: center">18 East 41<SUP>st</SUP> street 14<SUP>th</SUP>
  floor</P>
  
  <P STYLE="margin: 0; text-align: center">New York NY, 10017</P>
  
  <P STYLE="margin: 0; text-align: center">www.JSBarkats.com</P>
  
  <P STYLE="margin: 0; text-align: center">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Written communications pursuant to Rule
  425 under the Securities Act</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Soliciting material pursuant to Rule 14a-12
  under the Exchange Act&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant
  to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>
  
  <P STYLE="margin: 0; text-align: justify">[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
  (17 CFR 240.13e-4(c))</P>
  
  
  <!-- Field: Page; Sequence: 1 -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="margin: 0; text-align: justify"><B>Item 2.01 Completion of Acquisition
  or Disposition of Assets</B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">On December 17, 2014, GreeneStone Healthcare
  Corporation, a Colorado corporation (the &#8220;Registrant&#8221;), completed the sale of all of the outstanding shares of the
  Registrant&#8217;s Endoscopy subsidiary, 1816191 Ontario Ltd. (&#8220;1816&#8221;), for the sum of C$1,282,001.87, comprised of
  the agreed purchase price of C$1,250,000 and the acqusition of net assets at closing of C$32,001.87. The sale was made pursuant
  to that Share Purchase Agreement, dated as of October 6, 2014, by and between the Registration and Jaintheelal Parekh Medicine
  Professional Corporation (&#8220;Jaintheelal&#8221;). The Registrant and Jaintheelal entered into a revised Share Purchase Agreement
  on December 16, 2014.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Jaintheelal is owned by Dr. Jay Parekh, the
  Registrant&#8217;s former Medical director in charge of Endoscopy. The sale price of C$1,282,001.87 included the assumption by
  Jaintheelal of debt in the same amount as the sale price, which debt is owed by 1816 to the Registrant in the amount of $895,495.60
  and to Jaintheelal of $386,542.27. At closing, Jaintheelal offset the assumed debt to the registrant of $895,495.60 by $277,500.00
  through the cancellation of two million four hundred and eight thousand two hundred and sixty-eight shares of the Registrant&#8217;s
  common stock. The remainder of the assumed debt owed by 1816 to the Registrant is due June 30, 2015 and is in the form of an interest-bearing
  note.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom; background-color: white">
      <TD STYLE="margin: 0; text-align: justify; width: 10%"><B>Exhibit No.</B></TD>
      <TD STYLE="margin: 0; text-align: justify; width: 1%">&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify; width: 89%"><B>Description</B></TD></TR>
  <TR STYLE="background-color: white">
      <TD STYLE="margin: 0; text-align: left; vertical-align: top">10.1</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify"><A HREF="grst8k122314ex10_1.htm">Share Purchase Agreement, dated as of December 16, 2014, by and between the Registrant and Jaintheelal Parekh Medicine Professional Corporation.</A></TD></TR>
  <TR STYLE="background-color: white">
      <TD STYLE="margin: 0; text-align: justify">10.2</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="margin: 0; text-align: justify"><A HREF="grst8k122314ex10_2.htm">Collateral Note dated December 16, 2014</A></TD></TR>
  </TABLE>
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify"><B>&nbsp;</B></P>
  
  <P STYLE="margin-top: 0; margin-bottom: 0; text-align: center"><B>SIGNATURES</B></P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <P STYLE="margin: 0; text-align: justify">Pursuant to the requirements of
  the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
  thereunto duly authorized.</P>
  
  <P STYLE="margin: 0; text-align: justify">&nbsp;</P>
  
  <TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
      <TD STYLE="margin: 0; text-align: justify">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD COLSPAN="2" STYLE="text-align: center"><B>GREENESTONE HEALTHCARE CORPORATION </B></TD>
      <TD>&nbsp;</TD></TR>
  <TR>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="text-align: center">&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD></TR>
  <TR>
      <TD>Date: December 23, 2014</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: bottom">By:</TD>
      <TD STYLE="border-bottom: black 1pt solid"><I>/s/ Shawn E. Leon</I></TD>
      <TD>&nbsp;</TD></TR>
  <TR>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD STYLE="vertical-align: bottom">&nbsp;</TD>
      <TD>Name: Shawn E. Leon</TD>
      <TD>&nbsp;</TD></TR>
  <TR>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>&nbsp;</TD>
      <TD>Title: Chief Executive Officer</TD>
      <TD>&nbsp;</TD></TR>
  </TABLE>
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>
  
  <!-- Field: Page; Sequence: 2; Options: Last -->
      <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: left; width: 33%">&nbsp;</TD><TD STYLE="text-align: center; width: 34%">&nbsp;</TD><TD STYLE="text-align: right; width: 33%">&nbsp;</TD></TR></TABLE></DIV>
      <!-- Field: /Page -->
  
  <P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>
  
  
  </BODY>
  </HTML>
metadata_documents: [{"type": "8-K", "sequence": "1", "filename": "grst8k122314.htm", "secsgml_size_bytes": 9489}]
metadata_filer: {"company-data": {"conformed-name": "GREENESTONE HEALTHCARE CORP", "cik": "0000792935", "assigned-sic": "8062", "irs-number": "841227328", "state-of-incorporation": "CO", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-15078", "film-number": "141307112"}, "business-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7", "phone": "416-222-5501"}, "mail-address": {"street1": "5734 YONGE ST.", "street2": "SUITE 300", "city": "TORONTO", "state": "A6", "zip": "M2M 4E7"}, "former-company": {"former-conformed-name": "NOVA NATURAL RESOURCES CORP", "date-changed": "19920703"}}
text: UNITED STATES
  SECURITIES AND EXCHANGE COMMISSION
  Washington, D.C. 20549
  FORM 8-K
  CURRENT REPORT
  Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported):
  December 17, 2014
  GREENESTONE HEALTHCARE CORPORATION
  (Exact name of registrant as specified in its charter)
  Colorado
  000-15078
  84-1227328
  (State of Incorporation)
  (Commission File Number)
  (IRS Employer Number)
  5734 Yonge Street, Suite 300
  North York, Ontario, Canada M2M 4E7
  (Address of principal executive offices)
  (416) 222-5501
  (Registrant's telephone number, including
  area code)
  Prepared By:
  Attn: Sunny Barkats, Esq.,
  18 East 41
  st
  street 14
  th
  floor
  New York NY, 10017
  www.JSBarkats.com
  Check the appropriate box below if the Form
  8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
  [ ] Written communications pursuant to Rule
  425 under the Securities Act
  [ ] Soliciting material pursuant to Rule 14a-12
  under the Exchange Act
  [ ] Pre-commencement communications pursuant
  to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
  (17 CFR 240.13e-4(c))
  Item 2.01 Completion of Acquisition
  or Disposition of Assets
  On December 17, 2014, GreeneStone Healthcare
  Corporation, a Colorado corporation (the "Registrant"), completed the sale of all of the outstanding shares of the
  Registrant's Endoscopy subsidiary, 1816191 Ontario Ltd. ("1816"), for the sum of C$1,282,001.87, comprised of
  the agreed purchase price of C$1,250,000 and the acqusition of net assets at closing of C$32,001.87. The sale was made pursuant
  to that Share Purchase Agreement, dated as of October 6, 2014, by and between the Registration and Jaintheelal Parekh Medicine
  Professional Corporation ("Jaintheelal"). The Registrant and Jaintheelal entered into a revised Share Purchase Agreement
  on December 16, 2014.
  Jaintheelal is owned by Dr. Jay Parekh, the
  Registrant's former Medical director in charge of Endoscopy. The sale price of C$1,282,001.87 included the assumption by
  Jaintheelal of debt in the same amount as the sale price, which debt is owed by 1816 to the Registrant in the amount of $895,495.60
  and to Jaintheelal of $386,542.27. At closing, Jaintheelal offset the assumed debt to the registrant of $895,495.60 by $277,500.00
  through the cancellation of two million four hundred and eight thousand two hundred and sixty-eight shares of the Registrant's
  common stock. The remainder of the assumed debt owed by 1816 to the Registrant is due June 30, 2015 and is in the form of an interest-bearing
  note.
  Exhibit No.
  Description
  10.1
  Share Purchase Agreement, dated as of December 16, 2014, by and between the Registrant and Jaintheelal Parekh Medicine Professional Corporation.
  10.2
  Collateral Note dated December 16, 2014
  SIGNATURES
  Pursuant to the requirements of
  the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
  thereunto duly authorized.
  GREENESTONE HEALTHCARE CORPORATION
  Date: December 23, 2014
  By:
  /s/ Shawn E. Leon
  Name: Shawn E. Leon
  Title: Chief Executive Officer